Product image of Lexxema (Methylprednisolone Aceponate) supplied by GNH India

Lexxema

Active Ingredient:
Methylprednisolone Aceponate
Origin:
EU

Lexxema (Methylprednisolone Aceponate)

Methylprednisolone aceponate, the active ingredient in Lexxema, is a corticosteroid presented as a topical formulation for skin use. It treats inflammatory skin conditions such as eczema, psoriasis and dermatitis in adults and children as prescribed by a healthcare professional, providing anti‑inflammatory and immunosuppressive effects to alleviate symptoms.

GNH India supplies Lexxema as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality assurance, regulatory compliance and reliable logistics for global distribution. The company adheres to Good Distribution Practice and offers temperature‑controlled shipping where required.

Manufacturer / TM Owner

Italfarmaco S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Lexxema, a topical glucocorticoid, is used to manage inflammatory skin disorders.
  • Eczema: Reduces inflammation, itching and redness associated with atopic dermatitis.
  • Psoriasis: Decreases plaque formation and scaling in plaque psoriasis.
  • Dermatitis: Controls inflammation and relieves symptoms in contact or seborrheic dermatitis.
  • Other inflammatory skin disorders: Provides anti‑inflammatory relief in conditions such as lichen planus or discoid lupus erythematosus.

How It Works

  • Methylprednisolone aceponate penetrates the epidermis and binds to intracellular glucocorticoid receptors. The drug‑receptor complex translocates to the nucleus and interacts with glucocorticoid response elements, modulating gene transcription. This results in decreased synthesis of pro‑inflammatory cytokines, inhibition of leukocyte migration, and suppression of immune cell activation, producing potent anti‑inflammatory and immunosuppressive effects in the skin.

Side Effects

Topical application of Lexxema may be associated with local and systemic adverse reactions.

Common Side Effects

  • Skin irritation or burning sensation.
  • Dryness or peeling of the treated area.
  • Mild erythema.
  • Pruritus.
  • Folliculitis.

Serious or Rare Side Effects

  • Skin atrophy or thinning with prolonged use.
  • Telangiectasia formation.
  • Secondary infection (bacterial, fungal, viral).
  • Hypersensitivity reactions such as contact dermatitis.
  • Systemic adrenal suppression (rare).

Precautions & Warnings

Before using Lexxema, consider the following precautions.

  • Indication: Use only for the skin conditions prescribed by a qualified healthcare professional.
  • Duration: Limit continuous use to the shortest period necessary to control symptoms.
  • Age: Caution in pediatric patients; follow pediatric dosing recommendations.
  • Application site: Avoid use on broken skin, open wounds, or mucous membranes.
  • Concomitant therapy: Do not combine with other potent topical steroids without medical advice.
  • Store at room temperature: Keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Avoid Interactions

Lexxema may interact with other medicines; review the following.

Major Interactions (Avoid)

  • Systemic corticosteroids: May increase risk of systemic glucocorticoid effects.
  • CYP3A4 inhibitors (e.g., ketoconazole): Can raise local steroid levels.
  • Antifungal agents applied to the same area: May enhance absorption and side effects.
  • Immunosuppressants: Potential additive immunosuppression.
  • Phototherapy: May increase skin irritation.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs) used systemically: Monitor for systemic steroid side effects.
  • Antihistamines: No direct interaction but monitor skin response.
  • Herbal topical preparations: Assess for additive irritation.
  • Vaccines: Systemic immunosuppression may affect response if extensive absorption occurs.
  • Diabetes mellitus: Monitor blood glucose if systemic absorption is significant.

Frequently Asked Questions

Lexxema is prescribed for inflammatory skin conditions such as eczema (atopic dermatitis), psoriasis, various forms of dermatitis and other inflammatory dermatoses where a topical corticosteroid is indicated to reduce redness, swelling and itching.

Methylprednisolone aceponate binds to glucocorticoid receptors in skin cells, altering gene transcription. This suppresses the production of inflammatory mediators, reduces immune‑cell activity and limits vasodilation, resulting in decreased inflammation, redness and itching at the site of application.

The dosage and frequency of Lexxema are determined by the prescribing healthcare professional based on the severity of the condition, the area of skin involved and patient age. Patients should follow the exact instructions provided on the prescription label.

Safety data for methylprednisolone aceponate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To order Lexxema, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lexxema contains methylprednisolone aceponate, a mid‑ to high‑potency corticosteroid. Compared with lower‑potency agents such as hydrocortisone, it offers stronger anti‑inflammatory action, but it also carries a higher risk of local side effects if used excessively. Choice of steroid depends on disease severity and treatment duration.

Lexxema should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat and direct sunlight to maintain its stability and potency throughout its shelf life.

Apply a thin layer of Lexxema to the affected skin area once or twice daily, as directed by the prescriber. Gently rub the cream until it is absorbed, avoid covering the area with occlusive dressings unless instructed, and wash hands after application.

Serious risks include skin atrophy, telangiectasia, secondary infections, hypersensitivity reactions and, rarely, systemic adrenal suppression. These events are more likely with prolonged use, large surface‑area application or use under occlusion, and should be monitored by a healthcare professional.

Lexxema should be avoided in individuals with known hypersensitivity to methylprednisolone aceponate or any excipients, in patients with untreated fungal, bacterial or viral skin infections, and in those where a less potent corticosteroid would be sufficient, unless a specialist advises otherwise.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylprednisolone Aceponate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT